Authors,Title,Category,contributions
"Brendan J. Kelly, MD, MS (1,2); Ebbing Lautenbach, MD, MPH, MSCE (1,2); Jason Roy, PhD (5); Ayannah S. Fitzgerald, BSN (3,4); Layla A. Khatib, BS (3,4); Ize Imai, MS (4); Leigh Cressman, MA (2); Frederic D. Bushman, PhD (3); Ronald G. Collman, MD (3,4)  ",Interspecific interactions define respiratory Staphylococcus aureus infection risk during mechanical ventilation  ,Microbial Ecology of Bacterial Infection; Molecular Epidemiology of Infectious Diseases,Spatial Epidemiology of Infectious Diseases; Molecular Epidemiology of Infectious Diseases; Novel Infectious Diseases Diagnostics; Antibiotic and Healthcare Impacts on the Human Microbiome; Microbial Ecology of Bacterial Infection; Interventions to Modify the Human Microbiome
"Brendan J. Kelly, MD, MS (1,2,3); Selamawit Bekele (2,3); Sean Loughrey (2,3); Elizabeth Huang (2,3); Pam Tolomeo, MPH (2,3); Michael Z. David, MD, PhD (1,2,3); Ebbing Lautenbach, MD, MPH, MS (1,2,3); Jennifer H. Han, MD, MS (1,2,3); Matthew J. Ziegler, MD, MS (1,2,3) for the CDC Prevention Epicenters Program  ",Healthcare Micro-Environments Define Multidrug-Resistant Organism Persistence  ,Spatial Epidemiology of Infectious Diseases; Molecular Epidemiology of Infectious Diseases,Spatial Epidemiology of Infectious Diseases; Molecular Epidemiology of Infectious Diseases; Novel Infectious Diseases Diagnostics; Antibiotic and Healthcare Impacts on the Human Microbiome; Microbial Ecology of Bacterial Infection; Interventions to Modify the Human Microbiome
"Melissa Richard-Greenblatt, PhD (1); Matthew J. Ziegler, MD, MS (2,3); Valerie Bromberg (2); Elizabeth Huang (2); Hatem Abdallah (2); Pam Tolomeo, MS (2); Ebbing Lautenbach, MD, MPH, MS (2,3); Laurel Glaser, MD, PhD (1); Brendan J. Kelly, MD, MS (2,3)  ",Quantifying the Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Performance  ,Novel Infectious Diseases Diagnostics; Molecular Epidemiology of Infectious Diseases,Spatial Epidemiology of Infectious Diseases; Molecular Epidemiology of Infectious Diseases; Novel Infectious Diseases Diagnostics; Antibiotic and Healthcare Impacts on the Human Microbiome; Microbial Ecology of Bacterial Infection; Interventions to Modify the Human Microbiome
"James J. Harrigan, MD, PharmD (1); Hatem Abdallah (1); Erik L. Clarke, PhD (2); Arman Oganisian, MS (2); Jason A. Roy, PhD (4); Ebbing Lautenbach, MD, MPH, MS (1,2); Emily Reesey, MS (2); Magda Wernovsky (1); Pam Tolomeo, MPH (2); Zygmunt Morawski (5); Jerry Jacob, MD, MS (1,5); Michael A. Grippi, MD (3,5); Brendan J. Kelly, MD, MS (1,2)  ",Respiratory microbiome disruption and risk for ventilator-associated lower respiratory tract infection  ,Molecular Epidemiology of Infectious Diseases; Novel Infectious Diseases Diagnostics; Antibiotic and Healthcare Impacts on the Human Microbiome; Microbial Ecology of Bacterial Infection,Spatial Epidemiology of Infectious Diseases; Molecular Epidemiology of Infectious Diseases; Novel Infectious Diseases Diagnostics; Antibiotic and Healthcare Impacts on the Human Microbiome; Microbial Ecology of Bacterial Infection; Interventions to Modify the Human Microbiome